YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)


AddThis Social Bookmark Button

Injured by Neurontin?

Neurontin Suicide Link
Neurontin (Generic: Gabapentin) may be linked to suicide and suicide attempts. Neurontin is prescribed for epilepsy but has been prescribed for numerous off label uses. Neurontin was approved for sale in the mid-1990s as a treatment for epileptic seizures. However, it is believed that about 80% of all Neurontin prescriptions are written for conditions other than what the drug was approved to treat.

Neurontin Off Label Prescriptions
It is believed that Parke-Davis, which was acquired by Pfizer in 2000, had a systematic strategy to market and promote Neurontin for untested uses, such as chronic pain, bipolar disorder and migraines. It is not illegal for a doctor to prescribe a drug for conditions outside of those it was approved for, however it is illegal for a drug company to market a medication for off label uses. In July 2003, Dateline aired an investigation which accused Parke-Davis of deliberately falsifying medical information about Neurontin so doctors would prescribe the drug off label to treat a multitude of conditions. State and Federal prosecutors have launched investigations into the allegedly illegal marketing of Neurontin. In its year-long investigation, Dateline interviewed a former Parke-Davis scientist who alleges company officials encouraged him to persuade physicians to prescribe Neurontin for a number of disorders, including attention deficit disorder and bipolar disease, even though there was minimal preliminary data indicating that Neurontin could help patients with those diseases. 

In May 2003, The U.S. attorney's office in Boston said in court documents that the drug company Parke-Davis, now Pfizer, gave illegal kickbacks to doctors, including trips to Puerto Rico and tickets to the 1996 Summer Olympics in exchange for prescribing the anticonvulsant Neurontin. Below is a list of the off-label conditions that Neurontin was marketed to treat.  These 11 uses were never submitted to the Food & Drug Administration (FDA) for approval, yet illegally promoted.

  • Bipolar Disorder
  • Pain Syndromes, Peripheral Neuropathy, and Diabetic Neuropathy
  • Treatment of Epilepsy alone (as monotherapy)
  • Reflex Sympathetic Dystrophy (RSD)
  • Attention Deficit Disorder (ADD)
  • Restless Leg Syndrome (RLS)
  • Trigeminal Neuralgia
  • Post-Hepatic Neuralgia (PHN)
  • Essential Tremor Periodic Limb Movement
  • Migraine
  • Drug and Alcohol Withdrawal Seizures

If you or a loved one took Neurontin and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.

NeurontinRSS Feed

Pfizer Influenced Neurontin Studies

Nov 12, 2009 | Parker Waichman Alonso LLP
It has been known that Neurontin is associated with a significant—80 percent, accoring to a prior LA Times report—increase in suicidal ideation and actions. Now, Reuters, is reporting that internal Pfizer Inc. documents point to the drug maker having “altered or omitted unfavorable study findings to expand its epilepsy drug, Neurontin's, market,” citing U.S. researchers looking into how drug manufacturers massage research data. Pfizer is considered, said Reuters, the...

Neurontin Suicide Trial to Start Next Week

Jul 24, 2009 | Parker Waichman Alonso LLP
The first Neurontin suicide lawsuit is set to go to trial.  According to a report on Bloomberg.com, about 1200 similar Neurontin lawsuits are pending.Neurontin was approved by the U.S. Food & Drug Administration (FDA) in 1983 to treat partial complex seizures.  The drug quickly became a blockbuster, and by 2004, sales reached $3 billion per year.  Neurontin was made by Parke-Davis, a division of Warner-Lambert, which was acquired by Pfizer in 2000.The first Neurontin lawsuit...

Illegal Marketing of Neurontin Detailed

Jan 8, 2009 | Parker Waichman Alonso LLP
An article detailing the marketing of Neurontin  recently published in the New England Journal of Medicine (NEJM) sheds new light on the tactics used by drug makers to increase sales of their products.  In the case of Neurontin, these methods were uncovered because they were being used to illegally promote off-label uses of the drug.  However, the authors of the NEJM article contend that the same questionable  tactics are regularly  used to promote approved of uses of...

Epilepsy Drugs to Carry Suicide Warnings

Dec 17, 2008 | Parker Waichman Alonso LLP
Epilepsy drugs must now carry warnings about their suicide risks, the Food & Drug Administration (FDA) has announced.  The drugs subject to the new warning include those used to treat psychiatric disorders, migraine headaches and other conditions, as well as epilepsy.  Epilepsy drugs on the list are:Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, Tegretol XR) Clonazepam (marketed as Klonopin) Clorazepate (marketed as Tranxene) Divalproex sodium (marketed as Depakote,...

Pfizer Neurontin Studies Altered, Suppressed to Boost Sales

Oct 8, 2008 | Parker Waichman Alonso LLP
A lawsuit against Pfizer Inc. claims the drug maker delayed the release and altered the conclusions of Neurontin studies that did not support expanded use of the epilepsy drug.  Pfizer is just the latest drug maker accused of manipulating research in this way for marketing purposes.  Earlier this year, a Vioxx lawsuit accused Merck & Co. of omitting findings on cardiovascular problems and death rates in studies it funded.Documents detailing the allegedly-manipulated Neurontin...

More Neurontin News

Neurontin
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Was suicide attempted?


Did loved one commit suicide?


What condition was this medication prescribed to treat?

What additional medications were you taking at the time?

If patient did commit suicide, what was the method of suicide?

If patient did attempt or commit suicide, did patient ever attempt suicide previously?


Please describe any psychiatric conditions diagnosed before starting Neurontin:

Did Neurontin help the condition that it was prescribed for?



Please further describe side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2010 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising